Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Milos Opravil"'
Autor:
Patrick Schmid, Andrea Bregenzer, Milo Huber, Andri Rauch, Wolfram Jochum, Beat Müllhaupt, Pietro Vernazza, Milos Opravil, Rainer Weber, Swiss HIV Cohort Study
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138838 (2015)
To evaluate the diagnostic performance of seven non-invasive tests (NITs) of liver fibrosis and to assess fibrosis progression over time in HIV/HCV co-infected patients.Transient elastography (TE) and six blood tests were compared to histopathologica
Externí odkaz:
https://doaj.org/article/36aff50480254175b4608e8adbc31cb3
Autor:
Marie Ballif, Bruno Ledergerber, Manuel Battegay, Matthias Cavassini, Enos Bernasconi, Patrick Schmid, Bernard Hirschel, Hansjakob Furrer, Martin Rickenbach, Milos Opravil, Rainer Weber, Swiss HIV Cohort Study
Publikováno v:
PLoS ONE, Vol 4, Iss 12, p e8275 (2009)
BACKGROUND: Combination antiretroviral treatment (cART) has been very successful, especially among selected patients in clinical trials. The aim of this study was to describe outcomes of cART on the population level in a large national cohort. METHOD
Externí odkaz:
https://doaj.org/article/10de01a880e94e308404e0dbe04a25c9
Autor:
Michael Moddel, Rahel Pfammatter, Zsuzsanna Varga, Holger Moch, Gerald Keusch, Rudolf P. Wüthrich, Patrice M. Ambühl, Simone Schmid, M Huber, Milos Opravil
We performed a retrospective analysis on kidney biopsies of 30 human immunodeficiency virus (HIV)-positive patients. Twenty-two of them received highly active antiretroviral therapy (HAART). Tenofovir containing HAART together with atazanavir, a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6f02b73ce6d0e439c982c916642e72
http://doc.rero.ch/record/318008/files/428_2007_Article_418.pdf
http://doc.rero.ch/record/318008/files/428_2007_Article_418.pdf
Autor:
Lorenzo Magenta, Barbara Hasse, Bruno Ledergerber, Reto Nüesch, John M. Evison, Thomas Wagels, Jean-Philippe Zuber, Veronique Schiffer, Milos Opravil, Alexandra Calmy, Rudolf Speich, Rolf Jenni
Publikováno v:
Zuber, Jean-Philippe; Calmy, Alexandra; Evison, John M.; Hasse, Barbara; Schiffer, Veronique; Wagels, Thomas; Nuesch, Reto; Magenta, Lorenzo; Ledergerber, Bruno; Jenni, Rolf; Speich, Rudolf; Opravil, Milos (2004). Pulmonary Arterial Hypertension Related to HIV Infection: Improved Hemodynamics and Survival Associated with Antiretroviral Therapy. Clinical infectious diseases, 38(8), pp. 1178-1185. The University of Chicago Press 10.1086/383037
This study aimed to assess the long-term course of pulmonary arterial hypertension related to infection with human immunodeficiency virus (PAHRH) and the influence of antiretroviral therapy (ART) on its characteristics. We retrospectively analyzed al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa8d48c91ee8247ca0308c92c1cda68
http://doc.rero.ch/record/297761/files/38-8-1178.pdf
http://doc.rero.ch/record/297761/files/38-8-1178.pdf
Autor:
Enos Bernasconi, Hansjakob Furrer, Milos Opravil, Sabine Yerly, Rainer Weber, Marek Fischer, Huldrych F. Günthard, Bernard Hirschel, Leslie R. Bisset, Colin Howe, Manuel Battegay, Jean Philippe Chave, Pietro Vernazza, Bruno Ledergerber, Adriano Lazzarin, Luc Perrin
Publikováno v:
Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; Chave, Jean-Philippe; Yerly, Sabine; Bisset, Leslie R.; Fischer, Marek; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel; Ledergerber, Bruno; Günthard, Huldrych; Howe, Colin; Weber, Rainer; Perrin, Luc (2002). A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. Journal of infectious diseases, 185(9), pp. 1251-1260. The University of Chicago Press 10.1086/340312
The Journal of Infectious Diseases, Vol. 185, No 9 (2002) pp. 1251-1260
The Journal of Infectious Diseases, Vol. 185, No 9 (2002) pp. 1251-1260
This randomized study evaluated the efficacy and tolerability of continued treatment with protease inhibitor plus nucleoside-analogue combination regimens (n = 79) or a change to the simplified regimen of abacavir-lamivudine-zidovudine (n = 84) in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ae535520469334e4699c267e1912b4
http://doc.rero.ch/record/303577/files/185-9-1251.pdf
http://doc.rero.ch/record/303577/files/185-9-1251.pdf
Autor:
Milos Opravil, Huldrych F. Günthard, Hansjakob Furrer, Sabine Yerly, Viktor von Wyl, Heiner C. Bucher, Enos Bernasconi, Marcel Wolbers, Bernard Hirschel, Pietro Vernazza, Manuel Battegay, Matthias Cavassini
Publikováno v:
AIDS, Vol. 21, No 16 (2007) pp. 2201-2207
OBJECTIVE: To investigate predictors of continued HIV RNA viral load suppression in individuals switched to abacavir (ABC), lamivudine (3TC) and zidovudine (ZDV) after successful previous treatment with a protease inhibitor or non-nucleoside reverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec79c128fb782af714ed7f6d83341028
https://ora.ox.ac.uk/objects/uuid:828c5356-d01f-4a38-8056-544955900430
https://ora.ox.ac.uk/objects/uuid:828c5356-d01f-4a38-8056-544955900430
Autor:
Raymond T. Chung, Maribel Rodriguez-Torres, Andreas Tietz, Jürgen K. Rockstroh, Milos Opravil, Eric Snoeck, Francesca J. Torriani
Publikováno v:
HIV Clinical Trials. 13:33-45
Purpose: The relationship between peginterferon/ribavirin exposure and the probability of achieving a sustained virologic response (SVR) in HIV-HCV coinfected patients is not well described. We conducted a retrospective analysis of HIV-HCV coinfected
Autor:
Manuel Battegay, Enos Bernasconi, Heiner C. Bucher, Pietro Vernazza, Martin Rickenbach, Milos Opravil, Matthias Cavassini, Christoph A Fux, Huldrych F. Günthard, Bernard Hirschel, Alexandra U. Scherrer, Sabine Yerly, James Young, Jürg Böni
Publikováno v:
HIV Medicine. 12:299-307
Darunavir was designed for activity against HIV resistant to other protease inhibitors (PIs). We assessed the efficacy, tolerability and risk factors for virological failure of darunavir for treatment-experienced patients seen in clinical practice.
Autor:
Manuel Battegay, Enos Bernasconi, Milos Opravil, Christoph A Fux, Thomas Klimkait, Eva Wolf, Rainer Weber, Séverine Louvel, Martin Vogel, Roberto F. Speck
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 54:51-58
The M184V mutation decreases the replication capacity of HIV-1. This prospective study aimed to characterize the virologic and immunologic changes during monotherapy with lamivudine (3TC) in patients with limited options for a fully suppressive new t
Autor:
Alexandra U, Scherrer, Viktor, von Wyl, Christof A, Fux, Milos, Opravil, Heiner C, Bucher, Aurélie, Fayet, Laurent A, Decosterd, Bernhard, Hirschel, Bettina, Khanlari, Sabine, Yerly, Thomas, Klimkait, Hansjakob, Furrer, Bruno, Ledergerber, Huldrych F, Günthard, S, Yerly
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes; Vol 53
Journal of Acquired Immune Deficiency Syndromes, Vol. 53, No 4 (2010) pp. 464-471
Journal of Acquired Immune Deficiency Syndromes, Vol. 53, No 4 (2010) pp. 464-471
BACKGROUND: Raltegravir (RAL) achieved remarkable virologic suppression rates in randomized-clinical trials, but today efficacy data and factors for treatment failures in a routine clinical care setting are limited. METHODS: First, factors associated